Navigation Links
Treating Childhood Leukemia With Fewer Side Effects
Date:9/10/2009

Dutch researchers skip radiation treatments, some chemo but add corticosteroid

THURSDAY, Sept. 10 (HealthDay News) -- Adding the corticosteroid dexamethasone to the treatment regimen of children with acute lymphoblastic leukemia improves survival rates and reduces the incidence of the cancer recurring, a new Dutch study shows.

Acute lymphoblastic leukemia (ALL), a cancer of the blood, is the most common childhood cancer and is highly treatable, according to background information in the study.

But the researchers say that many children with ALL are over-treated with cranial radiation and chemotherapy drugs that cause significant side effects and may not be necessary to cure them.

The study found that a dexamethasone-based treatment can improve the cancer cure rate and reduce the risk of relapse without radiation and routinely used chemotherapy drugs. The findings were published online Sept. 9 The Lancet Oncology.

Dexamethasone is sold under the brand name Decadron.

The study involved 859 youths, aged 1 to 18, with ALL. About 30 percent of them were considered to be at high risk for recurrence.

Participants not at high risk were given a basic three-drug induction (dexamethasone, vincristine and L-asparaginase) and medium-dose methotrexate. High-risk youths were given a four-drug induction (the same three drugs as the others got plus four doses of daunorubicin), consolidation with methotrexate and two intensification courses before maintenance, which was 109 weeks for all participants.

Triple intrathecal chemo was given 13 times in those not at high risk, 15 times in high-risk youths and 17 times in those with initial central nervous system involvement. No one was given cranial radiation.

Five-year, cancer-free survival for the high-risk group was 72 percent, the study found. Those not at high risk had an 84 percent survival rate. About 70 percent of all people newly diagnosed are not at high risk, according to the researchers.

The results for those not at high risk "were achieved with high cumulative doses of dexamethasone and vincristine, but without the use of anthracyclines, etoposide, cyclophosphamide or cranial irradiation, therefore minimizing the risk of side effects," they said in a news release from the journal. The survival rate for the high-risk group also was described as favorable.

More information

The U.S. National Cancer Institute has more on acute lymphoblastic leukemia.



-- Jennifer Thomas



SOURCE: The Lancet Oncology, news release, Sept. 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating Childhood Leukemia With Fewer Side Effects
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: